US 11702411
Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitors
granted A61PA61P35/00
Quick answer
US patent 11702411 (Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitors) held by Revolution Medicines, Inc. expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Revolution Medicines, Inc.
- Grant date
- Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61P, A61P35/00